与次重性大动脉狭窄症进展相关的心脏结构和功能的改变:ARIC研究
Khaled Shelbaya1, Brian Claggett2, Pranav Dorbala2
1University of Texas Southwestern Medical Center Dallas TX USA.
Journal of the American Heart Association
|January 14, 2026
概括
大动脉狭窄 (AS) 的早期阶段与心脏变化有关,例如左心室质量增加. 随着AS的进展,这些心脏变化变得更糟,特别是与同时存在的异常.
科学领域:
- 心脏病学 心脏病学
- 心声回声图 (Echocardiography) 是一种心声回声图.
- 心血管疾病 心血管疾病
背景情况:
- 美国心脏协会和美国心脏病学院的指导方针定义了大动脉狭窄 (AS) 的4个阶段.
- 关于AS早期 (不严重) 阶段心脏变化的数据有限.
研究的目的:
- 在AS早期阶段调查心脏结构和功能.
- 评估AS进展对心脏指标的影响.
- 为了确定AS阶段进展的预测因素.
主要方法:
- 利用了来自社区动脉样硬化风险研究 (ARIC) 的数据.
- 在两个时间点 (V5和V7) 按AS阶段分类参与者,使用心声回声学.
- 使用多变量回归模型来分析AS阶段,进展和心脏参数之间的关联.
主要成果:
- 与第0阶段相比,AS早期阶段 (A和B) 与左心室壁厚度,质量和填充压力增加有关.
- AS阶段的进展与这些心脏指标的恶化有关 (P<0.02).
- 左心室和左心房异常的存在增加了AS阶段进展的可能性 (OR1.7,P=0.009).
结论:
- 早期的AS阶段与心脏重塑和腹功能障碍有关.
- AS阶段的进展导致心脏结构和功能的恶化.
- 同时存在的左心室和左心房异常预测了早期AS进展的更高风险.
相关概念视频
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
402
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
402
Aortic Regurgitation III: Medical Management
392
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
392
Rheumatic Heart Disease I: Introduction
426
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
426
Aortic Regurgitation I: Introduction
472
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
472
Mitral Stenosis I: Introduction
453
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
453
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
458
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
458


